The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
about
The pathophysiology of thrombocytopenia in chronic liver diseaseThrombin activation and liver inflammation in advanced hepatitis C virus infectionAutoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C.Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients.Overwhelming postsplenectomy infection syndrome in adults - a clinically preventable disease.Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy.Pathobiology and treatment of hepatitis virus-related thrombocytopenia.Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II studyMechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction.Prevalence of cirrhosis in patients with thrombocytopenia who receive bone marrow biopsy.Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting list.Population pharmacokinetic/pharmacodynamic modelling of eltrombopag in healthy volunteers and subjects with chronic liver disease.Abnormal platelet kinetics are detected before the occurrence of thrombocytopaenia in HBV-related liver disease.Management of thrombocytopenia due to liver cirrhosis: a reviewSerum thrombopoietin levels and its relationship with thrombocytopenia in patients with cirrhosis.Partial splenic embolization to permit continuation of systemic chemotherapy.Hepatitis B infection is associated with an increased incidence of thrombocytopenia in healthy adults without cirrhosis.Thrombocytopenia in chronic liver disease.Lusutrombopag increases hematocytes in a compensated liver cirrhosis patientShen-Cao granules formulated based on traditional Chinese medicine alleviates bone marrow suppression caused by platinum-based anticancer reagents.Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A cross-sectional studyChanges in platelet functional parameters and CD62 P expression in liver cirrhosisThe utility of thrombopoietin in predicting liver fibrosis in chronic hepatitis B.Apoptotic bone marrow CD34+ cells in cirrhotic patients.Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction.Use of Activated Recombinant Factor VII in Severe Bleeding - Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding.Hypersplenism: History and current status.Abnormal hematological indices in cirrhosis.Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection.Portal and splanchnic hemodynamics after partial splenic embolization in cirrhotic patients with hypersplenism.Perioperative safety analysis of transcatheter arterial chemoembolization for hepatocellular carcinoma patients with preprocedural leukopenia or thrombocytopenia.Splenic artery embolization as an adjunctive procedure for portal hypertension.Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease.The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus.Estimating the likelihood of sustained virological response in chronic hepatitis C therapy.
P2860
Q26749277-70862F3A-9D66-42B9-A4D7-8A59E2EB6153Q26749460-58C63C61-6ADE-49B3-9C59-B9AF675849BDQ33370546-BC5CA3F6-3B47-495B-A402-D1229028887BQ33370831-9DC51229-A9CB-48E6-B172-FC1AE648FD37Q33376165-8656748F-61AA-493B-BC83-1B0BF0060DC5Q33378222-9AE37FEC-EA91-4F3B-8DB3-379A635C8BF2Q33378977-06FC236D-CF2D-482F-A22B-8A6D24E8F6DFQ33394547-EED728F9-5423-49E2-80C5-ACE79821AE88Q33401660-13C359CA-7881-4256-A68D-47C754C07651Q33401841-F0A38AB0-2F60-4D84-BF15-8D41A360DE4FQ33402491-12F38793-7D45-4045-B080-5A171E01E2FAQ33405520-BDACC2BF-5217-4E53-AD66-9A853337B912Q33410866-28FC122D-5E7D-480C-AEB0-B346E44ED61DQ33413800-67D192ED-39B2-47CA-BC55-2C6966C6C8B9Q33413924-AF766295-0A1B-47F0-AF20-195F3BFCFC90Q33416172-F40AD526-EEEB-486F-B938-E1A8AC22DFF1Q33435269-38ADA6F9-4AAC-45F7-9A3C-0998AF7A7B6EQ33436901-D6625A87-FFC1-45B5-8D60-AEF5A3853BE2Q33436905-9119A373-4B75-4DA1-80E3-9C5FC0DFA1EBQ33440304-1FD6115B-1A59-474B-8E68-6711969197A6Q33441730-BA3E8C4E-5AC3-4420-BE85-698BDB02EB3BQ33442312-822DB389-A35C-4A1E-8079-759A8942ED4CQ33751569-3DC83898-50F7-44E2-A2C1-97029E185FC6Q33816016-1C45B092-3200-4983-8D26-1D5BA10B5C6DQ34863446-A90FC705-4E7F-4CEC-B82D-510E0BC3FA5AQ35001606-8F514562-D65E-41AC-95C7-7BBCB7D0517BQ35998366-BCC3F24F-C00D-4658-A88D-CD6FFEB5C484Q37289448-FC6D1C8E-E587-472F-AB6F-48045F0B4C7DQ37291711-629FD9C6-81FD-443B-8186-681EB1950522Q37534731-E367F4F8-A40B-449D-88A4-56C8F6C0D5CAQ38945007-8FB21377-5C47-46FA-919C-F4C6A97B593DQ40091865-EF7BAB99-DE89-4784-93DE-7BEB8DA23423Q41954984-56390274-1EFC-46BE-B0F4-B9561FA85021Q47142999-BD679384-9CEF-449D-941A-69A6B37AF8B5Q47561545-827117EA-AE01-4F91-A765-A6F1E2FB126EQ50558649-415CFD8E-7750-4274-B853-00555257A03D
P2860
The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
@ast
The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
@en
type
label
The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
@ast
The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
@en
prefLabel
The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
@ast
The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
@en
P2093
P2860
P921
P1476
The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis
@en
P2093
Ignacio Herrero
Jorge Quiroga
Raquel Rios
P2860
P304
P356
10.1111/J.1572-0241.2005.41543.X
P407
P577
2005-06-01T00:00:00Z